Patent · US Active

Detection of anti-neurochondrin autoantibody in patients with cerebellar ataxia or cerebellitis

US10112982B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignee

EUROIMMUN Medizinische Labordiagnostika AG · DE

Inventors

Ramona Miske · Lübeck, DE
Madeleine Scharf · Stade, DE
Lars Komorowski · Ratzeburg, DE
Yvonne Denno · Lübeck, DE
Christian Probst · Herrnburg, DE
Inga-Madeleine Dettmann · Ahrensboek, DE
Winfried Stöcker · Erkrath, DE
Bianca Teegen · Rehna, DE
Nico Melzer · Munster, DE
Heinz Wiendl · Munster, DE
Sven Meuth · Munster, DE

Key dates

Filing date	Mar 23, 2016
Grant date	Oct 30, 2018
Priority date	—
Expiry date	Mar 23, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/47
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Polypeptides including Neurochondrin and autoantibodies binding to polypeptides including Neurochondrin are provided. Methods for diagnosing or treating diseases associated with neurological symptoms or cancers are also provided. The methods of diagnosis may include detecting an autoantibody binding to Neurochondrin in a sample from a patient. The methods of treatment may include administering a polypeptide comprising Neurochondrin to a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.